Caplin Point Laboratories Limited Financial Overview
Caplin Point Laboratories Limited's market cap is currently ₹150.50B. The company's EPS TTM is ₹20.3; its P/E ratio is 25.56; and it has a dividend yield of 0.31%. Caplin Point Laboratories Limited is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
